IFNA1 Antikörper
-
- Target Alle IFNA1 Antikörper anzeigen
- IFNA1 (Interferon, alpha 1 (IFNA1))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IFNA1 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Synthetic peptide of human IFNA1/IFNA13
- Isotyp
- IgG
- Top Product
- Discover our top product IFNA1 Primärantikörper
-
anti-Interferon, alpha 1 (IFNA1) (AA 164-189), (C-Term) antibody
IFNA1 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB21762 unconjugated
anti-Interferon, alpha 1 (IFNA1) (AA 24-133) antibodyIFNA1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3C6 unconjugated
anti-Interferon, alpha 1 (IFNA1) (AA 24-189) antibodyIFNA1 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 1 (IFNA1) (AA 150-189) antibodyIFNA1 Reaktivität: Maus WB, IF (p), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 1 (IFNA1) (AA 1-189) antibodyIFNA1 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 1 (IFNA1) (AA 25-155) antibodyIFNA1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 1 (IFNA1) (C-Term) antibodyIFNA1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 1 (IFNA1) (AA 24-133) antibodyIFNA1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Interferon, alpha 1 (IFNA1) antibodyIFNA1 Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 1 (IFNA1) antibodyIFNA1 Reaktivität: Human WB, IF, FACS, IHC (fro) Wirt: Maus Monoclonal Feb-48 unconjugated
-
- Applikationshinweise
- IHC 1:30-1:150, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.96 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- IFNA1 (Interferon, alpha 1 (IFNA1))
- Andere Bezeichnung
- IFNA1/IFNA13 (IFNA1 Produkte)
- Synonyme
- IFL antikoerper, IFN antikoerper, IFN-ALPHA antikoerper, IFN-alphaD antikoerper, IFNA13 antikoerper, IFNA@ antikoerper, Ifa1 antikoerper, IFN-ALPHA-1 antikoerper, IFN1@ antikoerper, IFNA1 antikoerper, IFN-alpha antikoerper, IFN-gamma antikoerper, IFNA antikoerper, IFNA2 antikoerper, IFNA6 antikoerper, IFN-alpha1 antikoerper, interferon alpha 13 antikoerper, interferon alpha 1 antikoerper, interferon, alpha 1 antikoerper, interferon, alpha 13 antikoerper, interferon antikoerper, interferon-alpha 1 antikoerper, interferon, alpha, leukocyte antikoerper, interferon-alpha-14 antikoerper, IFNA13 antikoerper, IFNA1 antikoerper, Ifna1 antikoerper, ifna1 antikoerper, IFNA3 antikoerper, IFN-ALPHA-14 antikoerper
- Hintergrund
- IFNA1 (interferon-alpha) is a member of the Type I IFN (1) family best known for their antiviral activity. It is a key cytokine regulating the activity of B cells,T-helper cells (Th cells),cDCs and natural killer cells (NK cells). Interferon-alpha induces B cell maturation into plasma cells and immunoglobulin production. Interferon-alpha plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). Interferon-alpha was the first cytokine to show clinical benefit in the treatment of certain types of cancer,including melanoma,chronic myelogenous leukemia,and renal cancer.
- UniProt
- P01562
- Pathways
- JAK-STAT Signalweg, Hepatitis C
-
